Stanford University
Showing 21-30 of 13,025 Results
-
Gita Chu Abhiraman
Affiliate, Department Funds
Resident in MedicineBioGita Abhiraman is a resident physician in Internal Medicine at Stanford in the Translational Investigator Program. She completed her MD and PhD at Stanford in the Medical Scientist Training Program. Her PhD in Immunology was advised by Dr. Chris Garcia, in which she studied cytokine signaling, immune receptor structure, and protein engineering. Her major first author-works include solving the structure of the interleukin-21 signaling receptor complex. She also developed a cytokine "adapter" switch molecule with applications in cancer and autoimmune disease. Gita has been involved in several projects to engineer cytokines, including IL-21, IL-12, and IL-10, for diverse therapeutic applications. Prior to her graduate training, Gita completed a bachelor's degree in Physics with a focus in Biophysics at Harvard University. She previously conducted research in the lab of Dr. Stephanie Dougan at the Dana-Farber Cancer Institute.
-
Matthew Alexander Abikenari
MD Student with Scholarly Concentration in Molecular Basis of Medicine / Immunology, expected graduation Spring 2028
BioMatthew received his undergraduate degree Summa Cum Laude from UCLA, where he conducted full-time basic and clinical neuroscience research on molecular mechanisms underlying neuropsychiatric and neurodegenerative disease. He then pursued a graduate degree in Clinical Neuroscience at the University of Oxford as The Queen’s College Herbruck Scholar, an award granted to only one American student per year, completing a thesis on paraneoplastic autoimmunity and the genotypic and phenotypic architecture of meningiomas, alongside RNA sequencing and spatial–genomic analyses of malignant CNS tumors. As a medical student at Stanford University, he joined Dr. Michael Lim’s laboratory, gaining extensive experience in in vitro and in vivo immunology, stereotactic tumor implantations, and high-throughput transcriptomics to define mechanisms of immunosuppression in glioblastoma. His family’s experience with brain cancer continues to ground his work and deepen his commitment to understanding, and ultimately improving, neurosurgical oncology.
